Drug companies who participate in the patent pool hand over their patents to UNITAID, which makes those patents available to generic drug manufacturers. Part of the deal is that the generic drugs can only be sold in lower-income countries.
Read Whole Story
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.